Regulatory product record
CREDELIO CAT
Product identity, ingredients and source provenance from the regulatory catalogue. Linked clinical evidence has a separate review status.
Product identity
- Brand name
- CREDELIO CAT
- DIN
- 02526328
- DPD drug code
- 101542
- Regulatory category
- APPROVED_VET_DRUG
- Market status
- MARKETED
- Route(s)
- ORAL
- Pharmaceutical form(s)
- TABLET (CHEWABLE)
- Ingredients
- LOTILANER (12 MG)
- Species (DPD record)
- CATS
- Company
- ELANCO CANADA LIMITED (DIN owner)
Source and provenance
- Source dataset
- health_canada_dpd_marketed
- Source snapshot date
- Not available in this source
- Source record key
- 101542
- Archive fingerprint (SHA-256)
- 85cc3ce208af3aa57018c3d14d83f90220c436baef7455384b6d48d9774e1c88
Linked clinical reference
Clinical entries are linked through the active molecule. Check their species, formulation, source and review status separately from this product record.
Clinical evidence
Dose regimens0
No dose regimens recorded for this species selection.
Adverse effects200
These are counts of spontaneously reported events, not proven adverse effects, causal relationships, or incidence rates.
Bars compare report counts within each species; they do not show incidence.
More reportsFewer reportsDog
- Vomiting3,201 reports
- Diarrhoea1,543 reports
- Other abnormal test result NOS827 reports
- Lack of efficacy (ectoparasite) - tick NOS755 reports
- Lack of efficacy (bacteria) - Borrelia706 reports
- Seizure NOS695 reports
- Lethargy (see also Central nervous system depression in 'Neurological')625 reports
- Lethargy (see also Central nervous system depression in Neurological)596 reports
- Lack of efficacy (endoparasite) - heartworm538 reports
- Behavioural disorder NOS497 reports
- Lack of efficacy (ectoparasite) - flea494 reports
- Not eating439 reports
Cat
- Vomiting149 reports
- Lack of efficacy (ectoparasite) - flea143 reports
- Panting102 reports
- Behavioural disorder NOS96 reports
- Lethargy (see also Central nervous system depression in Neurological)80 reports
- Scratching65 reports
- Hyperactivity54 reports
- Not eating53 reports
- Itching47 reports
- Vocalisation45 reports
- Pruritus42 reports
- Lethargy (see also Central nervous system depression in 'Neurological')41 reports
Literature references14
References are linked to this drug. Species applicability is not recorded here, so the species filter does not narrow this list. Imported dates do not retain their original precision; confirm dates in the original citation.
- Oral lotilaner in 21 cats with naturally acquired harvest mite infestation.
Study summary not available in the imported record. Open the original citation to review the study.
- Efficacy of Credelio Quattro™ chewable tablets containing lotilaner, moxidectin, pyrantel, and praziquantel against Ctenocephalides felis and Rhipicephalus sanguineus infestations on dogs.
Study summary not available in the imported record. Open the original citation to review the study.
- Efficacy of a novel chewable tablet (Credelio Quattro™) containing lotilaner, moxidectin, praziquantel, and pyrantel for the prevention of heartworm disease (Dirofilaria immitis) in dogs.
Study summary not available in the imported record. Open the original citation to review the study.
- Long-term safety of Credelio Quattro™ (lotilaner, moxidectin, praziquantel, and pyrantel chewable tablets), a novel orally administered combination endectocide for dogs.
Study summary not available in the imported record. Open the original citation to review the study.
- Efficacy of Credelio Quattro™ (lotilaner, moxidectin, praziquantel, and pyrantel chewable tablets) and Credelio™ (lotilaner) chewable tablets in the prevention of Borrelia burgdorferi transmission from infected Ixodes scapularis in dogs.
Study summary not available in the imported record. Open the original citation to review the study.
Sources: PubMed, National Library of Medicine; openFDA, U.S. Food and Drug Administration.